Lopinavir/ritonavir

Lopinavir/ritonavir
Combination of
LopinavirProtease inhibitor
RitonavirProtease inhibitor (pharmacokinetic booster)
Clinical data
Trade namesKaletra, Aluvia
AHFS/Drugs.comMonograph
MedlinePlusa602015
License data
Pregnancy
category
  • AU: B3
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
KEGG
NIAID ChemDB
CompTox Dashboard (EPA)
 ☒NcheckY (what is this?)  (verify)

Lopinavir/ritonavir (LPV/r), sold under the brand name Kaletra among others, is a fixed-dose combination antiretroviral medication for the treatment and prevention of HIV/AIDS.[4] It combines lopinavir with a low dose of ritonavir.[4] It is generally recommended for use with other antiretrovirals.[4] It may be used for prevention after a needlestick injury or other potential exposure.[4] It is taken by mouth as a tablet, capsule, or solution.[4]

Common side effects include diarrhea, vomiting, feeling tired, headaches, and muscle pains.[4] Severe side effects may include pancreatitis, liver problems, and high blood sugar.[4] It is commonly used in pregnancy and it appears to be safe.[4] Both medications are HIV protease inhibitors.[4] Ritonavir functions by slowing down the breakdown of lopinavir.[4]

Lopinavir/ritonavir as a combination medication was approved for use in the United States in 2000.[4] It is on the World Health Organization's List of Essential Medicines.[5]

Medical uses

Lopinavir/ritonavir was once a preferred combination for HIV first-line therapy in the United States.[6] But due to its higher pill burden compared to other protease inhibitor-based regimens and increased gastrointestinal intolerance, it is no longer recommended to treatment-naive patients.[7]

Adverse effects

The most common adverse effects observed with lopinavir/ritonavir are diarrhea and nausea. In key clinical trials, moderate or severe diarrhea occurred in up to 27% of patients, and moderate/severe nausea in up to 16%.[2] Other common adverse effects include abdominal pain, asthenia, headache, vomiting and, particularly in children, rash.[2]

Lopinavir/ritonavir is anticipated to have varying degrees of interaction with other medications that are also CYP3A and/or P-gp substrates.[8]

People with a structural heart disease, preexisting conduction system abnormalities, ischaemic heart disease, or cardiomyopathies should use lopinavir/ritonavir with caution.[9]

In March 2011, the US Food and Drug Administration (FDA) notified healthcare professionals of serious health problems that have been reported in premature babies receiving lopinavir/ritonavir oral solution, probably because of its propylene glycol content. They recommend the use should be avoided in premature babies.[10]

History

Abbott Laboratories (now, via spinoff, Abbvie) was one of the earliest users of the Advanced Photon Source (APS), a national synchrotron-radiation light source at Argonne National Laboratory. One of the early research projects undertaken at the APS focused on proteins from the human immunodeficiency virus (HIV). Using the APS beam line for X-ray crystallography, researchers determined viral protein structures that allowed them to determine their approach to the development of HIV protease inhibitors, a key enzyme target that processes HIV polyproteins after infection, the function of which allows the lifecycle of the virus to proceed. As a result of this structure-based drug design approach using the Argonne APS, Abbott was able to develop new products that inhibit the protease, and therefore stop virus replication.[11][12]

Lopinavir was developed by Abbott in an attempt to improve upon the company's earlier protease inhibitor, ritonavir, specifically with regard to its serum protein-binding properties (reducing the interference by serum on protease enzyme inhibition) and its HIV resistance profile (reducing the ability of virus to evolve resistance to the drug).[12] Administered alone, lopinavir has insufficient bioavailability; however, like several HIV protease inhibitors, its blood levels are greatly increased by low doses of ritonavir, a potent inhibitor of intestinal and hepatic cytochrome P450 3A4, which would otherwise reduce drug levels through catabolism.[12]

Lopinavir/ritonavir was approved by the US Food and Drug Administration (FDA) in September 2000,[13][14] and in the European Union in March 2001.[3]

In March 2020, during the COVID-19 pandemic, the Israeli government announced that it would force AbbVie to license its patents for lopinavir/ritonavir. In response, AbbVie announced that it would cease enforcing its patents on the drug entirely.[15][16][17]

Society and culture

Cost

As a result of high prices and the spread of HIV infection, the government of Thailand issued a compulsory license in January 2007, to produce and/or import generic versions of lopinavir and ritonavir.[18] In response, Abbott Laboratories withdrew its registration for lopinavir and seven of their other new drugs in Thailand, citing the Thai government's lack of respect for patents.[19] Abbott's attitude has been denounced by several NGOs worldwide, including a netstrike initiated by Act Up-Paris and a public call to boycott all of Abbott's medicines by the French NGO AIDES.[20]

Available forms

Heat-stable pellets that can be taken by mouth have been developed for children.[21]

Research

See also: Coronavirus disease 2019 § Research, and COVID-19 drug repurposing research

While data for SARS-CoV-1 looked promising, the benefit in COVID-19 is unclear as of March 2020.[22] In 2020, a non-blinded, randomized trial found lopinavir/ritonavir was not useful to treat severe COVID-19.[23][22] In this trial the medication was started typically around 13 days after the start of symptoms.[22]

References

  1. ^ "Kaletra Product information". Health Canada. 19 March 2019. Retrieved 18 March 2020.
  2. ^ a b c "Kaletra- lopinavir and ritonavir tablet, film coated Kaletra- lopinavir and ritonavir solution". DailyMed. 26 December 2019. Retrieved 18 March 2020.
  3. ^ a b "Kaletra EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 18 February 2020.
  4. ^ a b c d e f g h i j k "Lopinavir and Ritonavir". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 28 November 2016.
  5. ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
  6. ^ "Adult and Adolescent Guidelines". AIDSinfo. 4 May 2006. Archived from the original on 6 May 2006. Retrieved 6 May 2006.
  7. ^ "What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient". AIDSinfo. 18 December 2019. p. Table 10. Antiretroviral Components or Regimens Not Recommended as Initial Therapy. Archived from the original on 31 August 2020. Retrieved 26 August 2020.
  8. ^ Zhang L, Zhang Y, Huang SM (19 October 2009). "Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions". Molecular Pharmaceutics. 6 (6): 1766–1774. doi:10.1021/mp900132e. PMID 19839641.
  9. ^ "FDA Issues Safety Labeling Changes for Kaletra". Medscape. 10 April 2009. Archived from the original on 10 September 2017. Retrieved 18 March 2020.
  10. ^ "Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies". Drugs.com. Archived from the original on 11 March 2011.
  11. ^ Foster C. "Research at Argonne helps Abbott Labs develop anti-HIV drug". Archived from the original on 22 October 2006. Retrieved 4 September 2006.
  12. ^ a b c Sham HL, Kempf DJ, Molla A, Marsh KC, Kumar GN, Chen CM, et al. (December 1998). "ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease". Antimicrobial Agents and Chemotherapy. 42 (12): 3218–3224. doi:10.1128/AAC.42.12.3218. PMC 106025. PMID 9835517.
  13. ^ "Drug Approval Package: Kaletra (Lopinavir/Ritonavir) NDA #21-226 & 21-251". U.S. Food and Drug Administration (FDA). 20 November 2001. Retrieved 18 March 2020.
  14. ^ "Generic Kaletra Availability". Drugs.com. Retrieved 18 February 2020.
  15. ^ Bonadio E, Baldini A (1 April 2020). "Drug companies should drop their patents and collaborate to fight coronavirus". The Conversation.
  16. ^ "Inoculating the world may mean reviving old curbs on patents". Pittsburgh Post-Gazette. Bloomberg. 14 April 2020. Retrieved 16 April 2020.
  17. ^ Scheer S (19 March 2020). "Israel approves generic HIV drug to treat COVID-19 despite doubts". Reuters. Retrieved 16 April 2020.
  18. ^ "Decree of Department of Disease Control, Ministry of Public Health, regarding exploitation of patent on drugs & medical supplies by the government on combination drug between lopinavir & ritonavir" (PDF). Archived from the original (PDF) on 17 July 2011.
  19. ^ 'Abbott pulls HIV drug in Thai patents protest', Financial Times (14 March 2007)
  20. ^ "People Living with HIV: Let's change the rules imposed by the pharmaceutical industry!" (PDF). AIDES. 1 July 2007. Archived from the original (PDF) on 20 October 2007.
  21. ^ Pasipanodya B, Kuwengwa R, Prust ML, Stewart B, Chakanyuka C, Murimwa T, et al. (December 2018). "Assessing the adoption of lopinavir/ritonavir oral pellets for HIV-positive children in Zimbabwe". Journal of the International AIDS Society. 21 (12): e25214. doi:10.1002/jia2.25214. PMC 6293134. PMID 30549217.
  22. ^ a b c McCreary EK, Pogue JM (April 2020). "Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options". Open Forum Infectious Diseases. 7 (4): ofaa105. doi:10.1093/ofid/ofaa105. PMC 7144823. PMID 32284951.
  23. ^ Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. (May 2020). "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19". The New England Journal of Medicine. 382 (19): 1787–1799. doi:10.1056/NEJMoa2001282. PMC 7121492. PMID 32187464. This randomized trial found that lopinavir–ritonavir treatment added to standard supportive care was not associated with clinical improvement or mortality in seriously ill patients with Covid-19 different from that associated with standard care alone.

Read other articles:

Universitas Pertahanan Indonesia

Universitas Pertahanan Republik IndonesiaIndonesian Defense UniversityMotoPraditya Wiratama Nagara Bhakti (Sansekerta)Moto dalam bahasa IndonesiaPerwira Utama Berjiwa Patriot yang Cerdas dan Pintar serta Siap Berbakti untuk Negara dan BangsaJenisUniversitas NegeriDidirikan11 Maret 2009RektorJonni MahrozaAlamatKawasan IPSC Sentul, Sukahati, Kec. Citeureup, Bogor, Jawa Barat, 16810, IndonesiaKampusUrbanNama julukanUnhan atau Unhan RI atau IDUAfiliasiKementerian PertahananKementerian Pendid...

 

جان بيير رامبال

جان بيير رامبال (بالفرنسية: Jean-Pierre Rampal)‏  معلومات شخصية الميلاد 7 يناير 1922(1922-01-07)مارسيليا الوفاة 20 مايو 2000 (78 سنة)باريس سبب الوفاة قصور القلب  مكان الدفن مقبرة مونبارناس  مواطنة فرنسا  الحياة العملية المدرسة الأم معهد باريس للموسيقى  المهنة عازف فلوت  [لغات...

 

VH1

Pour les articles homonymes, voir VH1 (homonymie). VH1CaractéristiquesCréation 1er janvier 1985Propriétaire Paramount Media NetworksFormat d'image 480i, 1080iLangue AnglaisPays États-UnisStatut Thématique nationale privéeSiège social New YorkSite web www.vh1.comDiffusionDiffusion Satellite, câble, IPTVmodifier - modifier le code - modifier Wikidata VH1 est une chaîne de télévision musicale américaine appartenant à Paramount Global. Le but initial de la chaîne était de faire co...

Lokomotif BB305

Lokomotif BB305BB 305 CFDData teknisSumber tenagaDiesel hidraulikProdusenNippon Sharyo, Jepang Jenbacher Werke AustriaCFD, PrancisSpesifikasi rodaNotasi Whyte0-4-4-0Susunan roda AARB-BKlasifikasi UICBo'Bo'DimensiLebar sepur1.067 mm (3 ft 6 in)Panjang11.734 mm (12 yd 2 ft 6,0 in)Lebar2.740 mm (3 yd 0 ft 0 in) (01 Nippon Sharyo)2.920 mm (3 yd 0 ft 7 in) (01, 02, dan 03) 2.870 mm (3 yd 0 ft 5 in) ...

 

Синелобый амазон

Синелобый амазон Научная классификация Домен:ЭукариотыЦарство:ЖивотныеПодцарство:ЭуметазоиБез ранга:Двусторонне-симметричныеБез ранга:ВторичноротыеТип:ХордовыеПодтип:ПозвоночныеИнфратип:ЧелюстноротыеНадкласс:ЧетвероногиеКлада:АмниотыКлада:ЗавропсидыКласс:Пт�...

 

James O'Donnell (politician)

American politician (1840–1915) For other people named James O'Donnell, see James O'Donnell (disambiguation). This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (January 2015) (Learn how and when to remove this message) James O'DonnellPort Huron Daily Times (Port Huron, MI), October 2, 1896Member of the U.S. House of&#...

The Pinnacle (Nairobi)

Skyscraper under construction in Nairobi For other uses, see Pinnacle (disambiguation). The PinnacleAlternative namesPinnacle TowersHotel chainHiltonGeneral informationStatusUnder construction, which might be resumed in November 2025TypeMixed Use CommercialLocationUpper HillTown or cityNairobiCountryKenyaCoordinates01°17′48″S 36°49′05″E / 1.29667°S 36.81806°E / -1.29667; 36.81806Groundbreaking23 May 2017CostSh20 billion (Est)HeightArchitectural1,050 feet (3...

 

Bo Bichette

American baseball player (born 1998) Baseball player Bo BichetteBichette with the Toronto Blue Jays in 2019Toronto Blue Jays – No. 11ShortstopBorn: (1998-03-05) March 5, 1998 (age 26)Orlando, Florida, U.S.Bats: RightThrows: RightMLB debutJuly 29, 2019, for the Toronto Blue JaysMLB statistics (through April 15, 2024)Batting average.297Home runs90Runs batted in317 Teams Toronto Blue Jays (2019–present) Career highlights and awards 2× All-Star (2021, 2023) 2× AL hit lea...

 

God Tussi Great Ho

God Tussi Great HoPoster rilis teatrikalSutradaraRumi JaffreyProduserAfzal KhanSohail KhanCeritaRumi JafferyYunus SajawalPemeranSalman KhanPriyanka ChopraAmitabh BachchanSohail KhanPenata musikSajid-WajidSinematograferAshok MehtaPenyuntingPranay PatelDistributorSohail Khan ProductionsT-SeriesEros InternationalTanggal rilis15 Agustus 2008Durasi153 menitNegaraIndiaBahasaHindiPendapatankotor₹18,5 juta (US$260,000)[1] God Tussi Great Ho (bahasa Indonesia: Tuhan Engkau Agung) a...

Broadway Books

American book publisher This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: Broadway Books – news · newspapers · books · scholar · JSTOR (April 2020) (Learn how and when to remove this message) Broadway BooksParent companyCrown Publishing Group (Random House)Founded1995Country of originUnited StatesHeadquarters ...

 

Повітряні сили Збройних сил України

Ця стаття потребує додаткових посилань на джерела для поліпшення її перевірності. Будь ласка, допоможіть удосконалити цю статтю, додавши посилання на надійні (авторитетні) джерела. Зверніться на сторінку обговорення за поясненнями та допоможіть виправити недоліки. Мат...

 

Новосолдатка (Воронежская область)

У этого термина существуют и другие значения, см. Новосолдатка. СелоНовосолдатка 51°14′50″ с. ш. 38°48′03″ в. д.HGЯO Страна  Россия Субъект Федерации Воронежская область Муниципальный район Репьёвский Сельское поселение Новосолдатское История и география Часово...

List of Belgian provinces by life expectancy

Belstat (2020—2022) Average values for 3-year period 2020–2022. Data source: Belstat. The table shows combined data from the official website of the agency [1] and the site For a healthy Belgium with reference to Belstat.[2] Administrative division of Belgium provinceor region overall male female sex gap Belgium on average 81.4 79.1 83.6 4.5 Flemish Brabant 82.9 80.8 85.0 4.2 Limburg 82.5 80.5 84.4 3.9 Walloon Brabant 82.5 80.3 84.5 4.2 Antwerp 82.3 80.4 84.2 3.8 West Fla...

 

結石

8 mmの腎結石 ヒトの胃石。全ての一人の患者から取られた。グリッドスケールは1 mm。 結石（けっせき、英: calculus）は、体内の器官または管の中で形成される物質（大抵は無機塩）の凝固物（英語版）である。結石の形成は結石症（lithiasis）と呼ばれる。結石は数多くの疾患を引き起こし得る。 結石症の種類 「結石の一覧（ドイツ語版）」も参照 泌尿器系における�...

 

قلادة ديفي

قلادة ديفيمعلومات عامةالبداية 1877 الاسم الأصل Davy Medal (بالإنجليزية) سُمِّي باسم همفري ديفي البلد المملكة المتحدة تمنحها الجمعية الملكية موقع الويب royalsociety.org… الكمية 140 تعديل - تعديل مصدري - تعديل ويكي بيانات قلادة ديفي (بالإنجليزية: Davy Medal)‏ هي وسام تمنحه الجمعية الملكية بلند�...

Mu isamaa, mu õnn ja rõõm

Mu isamaa, mu õnn ja rõõmB. Indonesia: Tanah airku, KebahagiaankuLagu kebangsaan EstoniaPenulis lirikJohann Voldemar Jannsen, 1869 (1869)KomponisFredrik (Friedrich) Pacius, 1848 (1848)Penggunaan1920 (1920)Penggunaan ulangMei 1990 (1990-05)PencabutanJuni 1940 (1940-06)SebelumnyaLagu Kebangsaan RSS EstoniaSampel audioMu isamaa, mu õnn ja rõõmberkasbantuan Sampel audioMu isamaa, mu õnn ja rõõmberkasbantuan Mu isamaa, mu õnn ja rõõm (Tanah airku, kebahagi...

 

DJI (perusahaan)

SZ DJI Technology Co., Ltd.DJI Phantom 4 ProNama dagangDJINama asli大疆创新科技有限公司JenisSwastaIndustri Teknologi Elektronik konsumen Videografi Fotografi Didirikan2006; 18 tahun lalu (2006)PendiriFrank Wang (Wāng Tāo)KantorpusatShenzhen, Guangdong, TiongkokWilayah operasiSeluruh duniaProduk Pesawat tanpa awak Kamera perekam Stabilisator kamera Flight platform Gimbal kamera Flight controller Sistem propulsi Pendapatan CN¥ 18 milyar (USD 2,83 milyar)[1] (2017)...

 

Videogioco di simulazione

Questa voce o sezione sull'argomento videogiochi di simulazione non cita le fonti necessarie o quelle presenti sono insufficienti. Puoi migliorare questa voce aggiungendo citazioni da fonti attendibili secondo le linee guida sull'uso delle fonti. Segui i suggerimenti del progetto di riferimento. Un videogioco di simulazione è una simulazione sotto forma di videogioco. Il gioco cerca di simulare un aspetto della realtà e in genere richiede un misto di abilità, fortuna e strategia. Si ...

G. E. Moore

English philosopher (1873–1958) For the cofounder of Intel, see Gordon Moore. G. E. MooreOM FBAMoore in 1914BornGeorge Edward Moore(1873-11-04)4 November 1873Hastings Lodge, Victoria Road, Dulwich Wood Park, Upper Norwood, London, EnglandDied24 October 1958(1958-10-24) (aged 84)Evelyn Nursing Home, Cambridge, EnglandOther namesMoore (colleagues)Bill (family)EducationTrinity College, Cambridge(B.A., 1896)SpouseDorothy ElyChildrenNicholas Moore, Timothy MooreRelativesThomas Stur...

 

Oregon Country

Early-19th-century U.S. fur trade district in North America Not to be confused with Oregon County. Oregon Country1818–1846 American and Hudson's Bay Company flags were used.CapitalOregon City (US)Fort St. James (British)Government• (British; 1818–1822) Governor Joseph Berens of Hudson's Bay Company• (British; 1822–1846) Governor John Pelly of Hudson's Bay Company• (U.S.; 1841–1843) Supreme Judge Ira Babcock• (U.S.; 1843–1845) Executive Committee• (...